MedPath

Degex Liquescence

DRUG FACTS:

Approved
Approval ID

c189b8ca-ef0a-41d5-98c1-eb0ecdba37c8

Product Type

HUMAN OTC DRUG LABEL

Effective Date

May 15, 2025

Manufacturers
FDA

Nutritional Specialties, Inc.

DUNS: 032744609

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Thuja Occidentalis, Ubidecarenonum, Conium Maculatum, Asterias Rubens, Germanium Metallicum, Lachesis Mutus, Bufo Rana, Carcinosin, Phosphorus

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code83027-0037
Product Classification
G
Generic Name
Thuja Occidentalis, Ubidecarenonum, Conium Maculatum, Asterias Rubens, Germanium Metallicum, Lachesis Mutus, Bufo Rana, Carcinosin, Phosphorus
Product Specifications
Route of AdministrationORAL
Effective DateMay 15, 2025
FDA Product Classification

INGREDIENTS (11)

THUJA OCCIDENTALIS LEAFY TWIGActive
Quantity: 6 [hp_X] in 1 mL
Code: 1NT28V9397
Classification: ACTIB
UBIDECARENONEActive
Quantity: 8 [hp_X] in 1 mL
Code: EJ27X76M46
Classification: ACTIB
CONIUM MACULATUM FLOWERING TOPActive
Quantity: 9 [hp_X] in 1 mL
Code: Q28R5GF371
Classification: ACTIB
ASTERIAS RUBENSActive
Quantity: 12 [hp_X] in 1 mL
Code: A7FYY9Q742
Classification: ACTIB
BUFO BUFO CUTANEOUS GLANDActive
Quantity: 12 [hp_X] in 1 mL
Code: Q59QU6N72Q
Classification: ACTIB
PHOSPHORUSActive
Quantity: 30 [hp_X] in 1 mL
Code: 27YLU75U4W
Classification: ACTIB
WATERInactive
Code: 059QF0KO0R
Classification: IACT
ALCOHOLInactive
Code: 3K9958V90M
Classification: IACT
GERMANIUMActive
Quantity: 12 [hp_X] in 1 mL
Code: 00072J7XWS
Classification: ACTIB
HUMAN BREAST TUMOR CELLActive
Quantity: 16 [hp_X] in 1 mL
Code: C62OO7VD9K
Classification: ACTIB
LACHESIS MUTA VENOMActive
Quantity: 12 [hp_X] in 1 mL
Code: VSW71SS07I
Classification: ACTIB

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 11/7/2023

PACKAGE LABEL DISPLAY:

Professional

Health Products

HOMEOPATHIC

NDC 83027-0037-1

DEGEX

LIQUESCENCE

4 FL. OZ (120 ml)

DEGEX LIQUESCENCE

INDICATIONS & USAGE SECTION

LOINC: 34067-9Updated: 3/27/2023

INDICATIONS:

Provides potentized homeo-nutritional support to aid in support of cellular function.†

†Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

OTC - ACTIVE INGREDIENT SECTION

LOINC: 55106-9Updated: 11/7/2023

ACTIVE INGREDIENTS:

Thuja Occidentalis 6X, 9X, Ubidecarenonum (CoQ10) 8X, Conium Maculatum 9X, 12X, Asterias Rubens 12X, Germanium Metallicum 12X, Lachesis Mutus 12X, Bufo Rana 12X, 30X, Carcinosin 16X, 30X, Phosphorus 30X, 60X.

OTC - PURPOSE SECTION

LOINC: 55105-1Updated: 3/27/2023

PURPOSE:

Provides potentized homeo-nutritional support to aid in support of cellular function.†

†Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

WARNINGS SECTION

LOINC: 34071-1Updated: 3/27/2023

WARNINGS:

Professional Use Only

If pregnant or breast-feeding, ask a health professional before use.

In case of overdose, get medical help or contact a Poison Control Center right away.

If condition worsens, seek medical attention.

KEEP OUT OF REACH OF CHILDREN

Do not use if tamper evident seal is broken or missing.

Store in a cool place after opening

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

LOINC: 50565-1Updated: 11/7/2023

KEEP OUT OF REACH OF CHILDREN:

In case of overdose, get medical help or contact a Poison Control Center right away.

DOSAGE & ADMINISTRATION SECTION

LOINC: 34068-7Updated: 3/27/2023

DIRECTIONS:

1/2 teaspoonful one to two times a day. Patients 12 years and under: Topical use only, to the navel area or forearm.

INACTIVE INGREDIENT SECTION

LOINC: 51727-6Updated: 3/27/2023

INACTIVE INGREDIENTS:

Alcohol USP 20%, Purified Water USP.

OTC - QUESTIONS SECTION

LOINC: 53413-1Updated: 3/27/2023

QUESTIONS:

MANUFACTURED EXCLUSIVELY FOR

NUTRITIONAL SPECIALTIES, INC.

PO BOX 97227

PITTSBURG, PA 15229

www.phpltd.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Degex Liquescence - FDA Drug Approval Details